COVID-19 Records

Transcript segment

Baric Transcribed Interview (Redacted), p.118 · baric_ti:utt:01022

Page text: p.118 · original PDF

Date
2026-04-10 09:00 (day precision)
Type
transcript segment · interview
recipient
Ralph S. Baric, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker
Christina Salazar
Okay. Like what does that range sometimes look like?

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. 2026-04-10 09:00 Christina Salazar open
    And do you know what RML was doing with that?
  2. 2026-04-10 09:00 Ralph S. Baric open
    RML, again, I'd have to look at the MTA agreement that would tell me what was in it. We would have to pull it from the MTA. I can tell you that during the pandemic we did hundreds of MTA agreements with research institutions in the United States. If you ask me if I can remember this one directly, I can't, because if I had a person in my lab who I would say, "Take care of this MTA agreement," and they would do it.
  3. 2026-04-10 09:00 Christina Salazar open
    Is it typical that the transmittal fee would be zero? I just don't know.
  4. 2026-04-10 09:00 Ralph S. Baric open
    It depends on how much money I would have.
  5. 2026-04-10 09:00 Christina Salazar
    Okay. Like what does that range sometimes look like?
  6. 2026-04-10 09:00 Ralph S. Baric open
    Whatever the shipping cost are. DC.Scheduling@LexitasLegal.com
  7. 2026-04-10 09:00 Christina Salazar open
    Okay. And how much are shipping costs?
  8. 2026-04-10 09:00 Ralph S. Baric open
    You know, I haven't shipped anything. I have somebody else I have to do it. We have a person who's trained as a shipper, and they take care of it.
  9. 2026-04-10 09:00 Christina Salazar open
    Okay. I want to go back to the DARPA question on PREEMPT. I'll show you this email, and I don't have another copy of it right now. But it is dated March 7, 2019. It's from Vineet Menarchery, and you have a couple of other folks on here from Autonomous Therapeutics. [Exhibit No. 3 shown.]

Full conversation →